Vertical Integration in Medicinal Cannabis: The Trend & How to Put Patients First
The Australian medicinal cannabis industry has matured rapidly over the past decade. What began as a small number of specialised prescribers and pharmacies has evolved into a highly competitive healthcare sector with hundreds of clinics, pharmacies, suppliers and support services operating across the country.
Alongside this growth, another trend has become increasingly common – vertical integration.
But what does this actually mean? Today, many medicinal cannabis businesses are no longer focused on a single part of the patient journey. Instead, they're building integrated healthcare ecosystems that connect clinics, pharmacies, dispensing, technology platforms, logistics and, in some cases, product supply.
Not only is vertical integration a tried and tested growth strategy but depending on which side of the coin lands, it may also be essential to remain competitive.
But as the industry evolves, one question deserves equal attention – how can businesses continue to grow while ensuring every clinical decision is made with the patient's best interests in mind?
What Does Vertical Integration Mean in Medicinal Cannabis?
Within the medicinal cannabis industry, vertical integration generally refers to one organisation participating in multiple stages of a patient's healthcare journey.
This can include:
Patient acquisition and appointments
Telehealth or in-person medical clinics
Nurse-led screening
Prescribing doctors or nurse practitioners
Partner or owned pharmacies
Dispensing and delivery
Wholesale and distribution
Technology platforms that manage consultations, prescriptions and follow-up care
In some business models, cultivation, manufacturing or product distribution
Rather than relying on numerous independent providers, many organisations aim to offer patients a more connected experience through a single healthcare network.
Why Vertical Integration Is Becoming More Common
Several factors are driving this shift across the Australian medicinal cannabis sector.
Increasing Competition. The number of clinics entering the market has grown significantly. As patient acquisition becomes more competitive and advertising restrictions continue to tighten, businesses are looking for ways to improve efficiency and strengthen long-term sustainability. Vertical integration allows organisations to capture value across more of the patient journey rather than relying on a single service.
A Better Patient Experience. Medicinal cannabis patients often interact with multiple providers before receiving treatment. Booking appointments, obtaining prescriptions, coordinating with pharmacies and arranging medication delivery can become frustrating if communication between providers is inconsistent. Integrated models can reduce these pain points by creating smoother handovers between each stage of care. For patients, this often means fewer delays, clearer communication and a more streamlined experience.
Greater Operational Efficiency. Integrated businesses can often coordinate clinical teams, pharmacists and administrative staff more effectively. Shared systems may reduce duplicated work, improve communication and allow patients to receive more timely support throughout their treatment journey.
Long-Term Business Sustainability. Australia's medicinal cannabis industry continues to evolve, with increasing regulatory oversight, changing market dynamics and ongoing pressure on margins. Many businesses view vertical integration as an important strategy for maintaining quality, improving efficiency and remaining commercially sustainable over the long term.
Can Vertical Integration Become Essential?
As the market matures, vertically integrated businesses may gain several advantages over standalone providers.
Integrated organisations often have greater control over the patient journey, allowing them to not only improve coordination between healthcare professionals but also invest in technology + patient support, and reduce administrative costs. Patients also get a more consistent experience within one clinic.
However, this doesn’t necessarily mean every clinic must become fully integrated.
But the trend remains clear: partnerships between clinics, pharmacies, technology providers and other healthcare organisations are likely to become increasingly common as businesses look for ways to deliver efficient, scalable care.
The Ethical Considerations
While vertical integration offers many operational benefits, it also introduces important responsibilities.
In medicinal cannabis, businesses may have commercial interests across several parts of the healthcare pathway. This creates the potential for perceived or actual conflicts of interest if appropriate governance and clinical independence are not maintained.
For example, questions may arise when businesses have influence over prescribing, dispensing and product supply within the same organisation.
This does not mean vertically integrated models are inappropriate. Many operate with strong governance, ethical frameworks and high clinical standards.
However, maintaining patient trust requires transparency and a clear separation between commercial objectives and clinical decision-making.
Healthcare professionals should always be free to exercise independent clinical judgement based on the individual needs of each patient.
Why Patient-First Care Must Remain the Foundation
Medicinal cannabis treatment – like most other specialised healthcare treatments – is highly individual. Patients have different medical histories, treatment goals, budgets, preferences and responses to therapy. No single clinic, pharmacy or product will be the right fit for everyone.
A genuinely patient-first approach means:
Clinical recommendations are based on evidence and individual patient needs.
Patients receive balanced information about their treatment options.
Prescribers maintain independent clinical judgement.
Pharmacy and dispensing decisions prioritise patient access and continuity of care.
Businesses are transparent about commercial relationships where appropriate.
Success is measured by patient outcomes, not simply patient numbers.
The strongest healthcare organisations recognise that trust is their most valuable asset and trust is built when patients feel confident that every recommendation is made for their benefit.
Learn More
EQWELLIBRIYUM offers end-to-end consulting for organisations navigating the medicinal cannabis market in Australia. With strategic insights and operational frameworks that are designed to help you thrive, we’re here to help you. Learn more by contacting us today at hello@eqwellibriyum.com.
Substitution Regulations Download
Sign up to our mailing list to receive a complimentary outline of the substitution regulations per state and territory within Australia.
Reference List
Department of Veterans’ Affairs. Medicinal cannabis. Updated 16 February 2026. https://www.dva.gov.au/what-we-help-with/health-support/help-to-cover-healthcare-costs/manage-medicine-and-keep-costs-down/medicinal-cannabis
Department of Veterans’ Affairs. Updated medicinal cannabis framework supports safe and effective prescribing practices. 2026. https://www.dva.gov.au/providers/provider-news/updated-medicinal-cannabis-framework-supports-safe-and-effective-prescribing-practices
Department of Veterans’ Affairs. Medicinal cannabis framework – frequently asked questions. 2026. https://www.dva.gov.au/what-we-help-with/health-support/help-to-cover-healthcare-costs/manage-medicine-and-keep-costs-down/medicinal-cannabis/medicinal-cannabis-framework-frequently-asked-questions
The Medical Republic. DVA says no to telehealth cannabis prescribers. 2026. https://www.medicalrepublic.com.au/dva-says-no-to-telehealth-cannabis-prescribers/123296RSL Australia.
RSL welcomes DVA action on medicinal cannabis. 2026. https://www.rslaustralia.org/latest-news/rsl-welcomes-dva-action-on-medicinal-cannabis